Document is current

Article History

Accepted: 15 April 2021

First Online: 26 April 2021

Declarations

:

: All institutional and national guidelines for the care and use of laboratory animals were followed.

: All authors give consent for publication.

: Y.C.K., L.M.E., H.T.H., and J.H. are inventors on patents/patent applications related to this technology. J.H. and L.M.E. are co-founders of a start-up company planning to develop the eye drop technology for clinical use. DJZ and CAB are inventors on patents related to sunitinib and neuroprotection. Some of these patents have been licensed to Graybug Vision and to Oriole Therapeutics. J.H. is a co-founder and equity owner of Graybug Vision, and both J.H. and Johns Hopkins own company stock. DJZ is a co-founder and equity owner in Oriole Therapeutics. These arrangements have been reviewed and approved by the Johns Hopkins University in accordance with its conflict of interest policies. All other authors declare that they have no competing interests.

: The contents is solely the responsibility of the authors and does not necessarily represent the official view of the NCATS or NIH.